Heart Failure with Preserved Ejection Fraction, Heart Failure research hub

J3E-MC-EZDB: A Phase 2, Randomized, Double-Blind, Placebo-Controlled Study to Investigate the Efficacy and Safety of LY3540378 in Adults with Worsening Chronic Heart Failure with Preserved Ejection Fraction (HFpEF)

This study is looking into a new medication called LY3540378 for people with a type of heart failure where the heart struggles to relax properly. Researchers want to see if this new medicine can help improve how the heart works and if it's safe to use.